Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

184 Press Releases
DateTitleCompany
26 Jun 15 Takeda Announces New Assignment of Directors Takeda,
Published by
PharmiWeb.com
23 Jun 15 Takeda Announces CFO François-Xavier Roger to Join Nestlé S.A. Takeda,
Published by
PharmiWeb.com
12 Jun 15 Takeda's Statement on the Order Issued by the Japanese Ministry of Health Labour and Welfare regarding the Pharmaceutical and Medical Device Act Takeda,
Published by
PharmiWeb.com
08 Jun 15 Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions Takeda,
Published by
PharmiWeb.com
05 Jun 15 Final NICE guidance published on Entyvio® ? (vedolizumab), the first gut-selective treatment for ulcerative colitis TAKEDA,
Published by
PharmiWeb.com
03 Jun 15 Takeda Announces Consolidation of U.S. Vaccine Sites in Boston/Cambridge Area Takeda,
Published by
PharmiWeb.com
02 Jun 15 Takeda Announces Consolidation of U.S. Vaccine Sites in Boston/Cambridge Area Takeda Pharmaceuticals Company Limited,
Published by
Business Wire
12 May 15 Takeda Announces First Patient Enrolled in Global Phase 3 Study of Ixazomib as Maintenance Therapy for Newly Diagnosed Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
24 Mar 15 Takeda Licenses Rights to Use ImmunoGen, Inc.'s Novel Antibody-Drug Conjugate Technology Takeda, ImmunoGen,
Published by
PharmiWeb.com
11 Mar 15 Takeda Announces Publication in The Lancet of a Post Hoc Analysis of Data from the EXAMINE Cardiovascular Safety Outcomes Trial Takeda,
Published by
PharmiWeb.com
09 Mar 15 Completion of donations to Takeda's Support for Japan's Vitality and Recovery Program activities that support reconstruction in the areas affected by the Great East Japan Earthquake Takeda,
Published by
PharmiWeb.com
06 Mar 15 Takeda Announces Appointment of Christophe Weber as Chief Executive Officer Takeda,
Published by
PharmiWeb.com
20 Feb 15 Queen Mary University of London and Takeda Announce Research Collaboration To Develop Novel Therapies in Gastroenterology Takeda Pharmaceutical Company Limited,
Published by
Business Wire
10 Feb 15 Takeda Announces That the First Interim Analysis of the Phase 3 Study of Oral Ixazomib in Patients with Relapsed or Refractory Multiple Myeloma Met the Primary Endpoint of Improvement in Progression-Free Survival Takeda Pharmaceutical Company Limited,
Published by
Business Wire
06 Feb 15 The Possible Project Enters Collaboration with Takeda Oncology Takeda Oncology,
Published by
Business Wire
11 Dec 14 “¡Hola Mexico – we’re on our way to the World Cup!” Takeda UK
01 Dec 14 Takeda’s Investigational Oral Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation by U.S. FDA for Relapsed or Refractory Systemic Light-chain Amyloidosis Takeda Pharmaceutical Company Limited,
Published by
Business Wire
27 Nov 14 Entyvio® (vedolizumab) becomes first biologic treatment to receive provisional yes from NICE for maintenance therapy in ulcerative colitis, a condition that affects over 140,000 Britons Takeda UK Limited
27 Oct 14 Manage Your Reflux Symptoms: The Food4GERD App Takeda Pharmaceuticals International GmbH,
Published by
PR Newswire
21 Oct 14 Multiple Scientific Posters Supporting the Efficacy, Safety and Tolerability of Once-daily Latuda (lurasidone) are Presented at the 27th ECNP Congress Takeda Pharmaceuticals, Sunovion Pharmaceuticals
08 Oct 14 Takeda Appoints New Head of Vaccine Development Takeda Pharmaceuticals International, Inc.,
Published by
Business Wire
25 Sep 14 BioMotiv and Takeda Pharmaceutical Company Enter into Strategic Partnership Takeda Pharmaceutical,
Published by
Business Wire
19 Jun 14 Takeda Announces Termination of Orteronel (TAK-700) Development for Prostate Cancer in Japan, U.S.A. and Europe Takeda Pharmaceutical Company Limited,
Published by
Business Wire
16 May 14 Orteronel Plus Prednisone Improved Progression Free Survival in Men With Chemotherapy-Naïve Metastatic Castration Resistant Prostate Cancer in Phase 3 Study Takeda Pharmaceutical Company Limited,
Published by
Business Wire
18 Mar 14 Takeda Appoints Giles Platford Head of Emerging Markets Takeda Pharmaceuticals International,
Published by
PR Newswire
03 Mar 14 Sunovion and Takeda Announce Results from a New Study Showing Maintenance Treatment with Lurasidone Reduced the Risk of Relapse in Adults with Schizophrenia Sunovion & Takeda
29 Jan 14 Dainippon Sumitomo Pharma and Takeda Receive Positive CHMP Opinion for Lurasidone - a New Atypical Antipsychotic Medication for Adults with Schizophrenia Dainippon Sumitomo Pharma and Takeda
27 Dec 13 Takeda Announces Termination of Fasiglifam (TAK-875) Development Takeda Pharmaceutical Company Limited,
Published by
Business Wire
15 Oct 13 Five Scientific Posters Supporting the Efficacy and Tolerability of Once-Daily Lurasidone – A New Atypical Antipsychotic treatment for Adults with Schizophrenia Takeda Pharmaceuticals International GmbH
23 Sep 13 NORGINE AND TAKEDA ANNOUNCE THE NEW DRUG APPLICATION APPROVAL OF OBLEAN® (cetilistat) TABLETS 120MG IN JAPAN Norgine and Takeda Pharmaceutical Company Limited,
Published by
Pharmiweb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.